In The News

October 15, 2020

Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas” ) and iota Biosciences, Inc. (Co-founders and Co-CEOs: Michel Maharbiz, Ph.D. and Jose Carmena, Ph.D., “iota”) announced today that Astellas through a U.S. subsidiary, and iota have entered into a Merger Agreement pursuant to which Astellas will acquire iota.

September 13, 2019

Astellas Pharma Inc. and iota Biosciences, Inc. today announced a joint research and development agreement to explore new biosensing and treatment measures using ultra-small implantable medical devices.

Healthcare IT News

May 20, 2019

One company is working on cutting-edge technology that could change the way providers treat neurological diseases.

January 3, 2019

Berkeley company’s implantable technology interfaces directly with nerves to precisely treat diseases

December 27, 2018

Fitness trackers and heart-rate monitors are all well and good, but if you want to track activity inside the body, the solutions aren’t nearly as convenient. Iota Biosciences wants to change that with millimeter-wide sensors that can live more or less permanently in your body and transmit wirelessly what they detect, and a $15 million Series A should put them well on their way.

January 6, 2018

Brain-computer interfaces sound like the stuff of science fiction. Andrew Palmer sorts the reality from the hype.

July 14, 2017

Neural Dust, developed by Professors Jose Carmena and Michel Maharbiz at the University of California, Berkeley, awarded the prestigious 2017 McKnight Technological Innovation in Neuroscience Award

August 8, 2016

Tiny ultrasound-powered motes could record and adjust nerve activity. Here are 4 challenges that researchers at the University of California, Berkeley are tackling in order to bring this technology into the clinic.

August 8, 2016

A technology with the potential to blur the boundaries between biology and electronics has just leaped a major hurdle in the race to demonstrate its feasibility. A team at the University of California, Berkeley, led by neuroscientist Jose Carmena and electrical and computer engineer Michel Maharbiz, has provided the first demonstration of what the researchers call “ultrasonic neural dust” to monitor neural activity in a live animal.

August 5, 2016

Wireless sensors that can be implanted in a person’s body to control robotic devices have been developed by researchers hoping to transform brain-to-computer interfaces. The “groundbreaking” wireless device is smaller than a grain of rice and could revolutionize prosthetics.

August 4, 2016

Tiny implantable sensors that could be used to internally monitor the body without the need of wires have been created by engineers in the US. The devices, created by researchers at the University of California, Berkeley, could potentially treat disorders such as epilepsy or bladder control and in the future, control prosthetics.

August 4, 2016

Sensors the size of a grain of sand could one day explain what’s happening in your body from the inside out.

August 3, 2016

“Neural dust” wireless, implantable sensors are currently only 3 millimeters in length. This new healthcare tech could be even more groundbreaking, as scientists are working to shrink the sensors to microns wide, about the width of a human hair.

August 3, 2016

A tiny implant the size of a grain of sand has been created that can connect computers to the human body without the need for wires or batteries, opening up a host of futuristic possibilities. The devices, dubbed “neural dust”, could be used to continually monitor organs like the heart in real time and, if they can be made even smaller, implanted into the brain to control robotic devices like prosthetic arms or legs.

August 3, 2016

UC Berkeley engineers have built the first dust-sized, wireless sensors that can be implanted in the body, bringing closer the day when a Fitbit-like device could monitor internal nerves, muscles or organs in real time.

July 17th, 2013

Imagine thousands of particle-sized CMOS chips living in your brain.

Our Mission

iota Biosciences is dedicated to transforming how doctors monitor and treat disease by advancing our understanding of how bioelectronics can interact with the human nervous system. Building on award-winning “neural dust” technology developed by researchers at the University of California, Berkeley, iota is building a platform for the future of bioelectronic medicine.

Discover The Future

Contact Us
Go to Top